Drug Safety

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

PER's Breast Cancer Symposia in San Antonio

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

Updates from the Annual Hematology Meeting: Matching the Tumor with Patient Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

Oncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of CLL

Bridging Clinical Gaps in Indolent and Aggressive B-Cell Lymphomas: The Investigators Demonstrate How Novel Mechanisms Will Impact Your Practice Tomorrow

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

Medical Crossfire®: Clinical Decision-Making Under New Paradigms for HR+/HER2- Breast Cancer

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

Follicular Lymphoma Workshop: Forging Patient-Centric Plans with Targeted Therapies Across Lines of Care

Advances In™ Desmoid Tumors: Recognizing Disease Burden, Pathophysiology, and Targeted Treatments in Development

Advances In™: Meeting Unmet Clinical Needs in TNBC and HR+ Breast Cancer with TROP2-Targeted Regimens

Oncology Consultations®: Clinical Impact of HER2-Low Expressing Breast Cancer and Novel Targeted Therapies to Address Unmet Needs in Care

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

Medical Crossfire®: What Strategies Can the Care Team Implement to Optimize the Management of Pediatric Patients with NF1?

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GVHD?

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow

School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Trekking Through the Latest Updates for ROS1-Targeted Therapies

Mapping Out the Role of Emerging Biomarkers and Testing in NSCLC

Community Practice Connections™: Clinical Decision Making Under New Paradigms for HR+/HER2-Breast Cancer

Navigating the Latest Data on NTRK-Targeted Therapies

Oncology Roundtable: Treating MF and PV in 2023

Bridging Unmet Needs for Patients with Soft Tissue Sarcoma: Progress Toward Individualization of Care

Keeping Pace with Rapid Advancements in Multiple Myeloma Care

Maximizing Our Clinical Practices in Hodgkin Lymphoma: Integration of Recent Data Sets in Real World Settings

Community Practice Connections™: Matching the Tumor With Patient-Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia